依维莫司
医学
放射性核素治疗
内科学
恶心
神经内分泌肿瘤
中性粒细胞减少症
临床终点
粘膜炎
胃肠病学
无进展生存期
肺炎
毒性
外科
临床试验
化疗
肺
作者
Ali Aljubran,Ahmed Badran,Mohamed Alrowaily,Hussein Raef,Ahmed Alzahrani,Ahmed Almuhaideb,Hadeel Almanea,Abdelmoneim Eldali,Mahmoud Tuli,Shouki Bazarbashi
标识
DOI：10.1089/cbr.2022.0043
摘要
Both everolimus and peptide receptor radionuclide therapy (PRRT) are approved as monotherapies for advanced neuroendocrine tumors (NETs). Research in animal models showed synergism between the two treatment modalities. This study evaluate the safety and efficacy of combining everolimus and PRRT for the treatment of unresectable NETs.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
CAOHOU
yx_cheng
Nico
乐乐乐乐乐乐
23
eric888
核桃
勤劳的猕猴桃
代芙
Sandy
CJ
GingerF
YifanWang
aldehyde
lanxinyue
COSMAO
FIN
比比谁的速度快
22222
大家一起发发发
皖公网安备34019202002308
